Original Research

Efficacy and Tolerability of Fixed-Combination Acne Treatment in Adolescents

Acne is common among adolescents and can be difficult to manage. Providing an effective treatment method that offers an early onset of action and a favorable tolerability profile may lead to improved adherence, increased satisfaction, and improved clinical outcomes in this patient population. A post hoc analysis was conducted of 1755 adolescents (age range, 12 to

Significantly superior reductions in inflammatory, noninflammatory, and total lesion counts were observed in the CP 1.2%–BPO 2.5% gel group versus the other 3 groups (P≤.002 for all week 12 pairwise comparisons). At week 12, treatment success with CP 1.2%–BPO 2.5% gel was statistically superior to CP 1.2% (P=.004), BPO 2.5% (P=.031), and vehicle (P<.001 participants observed improvement with cp gel treatment as early week of reporting their skin was clear almost or showed marked improvement. clindamycin phosphate associated a low incidence treatment-related adverse events and favorable cutaneous tolerability profile.>


 

Recommended Reading

New Acne Treatment to Hit U.S. Market
MDedge Dermatology
Limit Oral Acne Antibiotics to 3 Months
MDedge Dermatology
Acne 101: Educate Patients Before Topical Therapy
MDedge Dermatology
Nanoparticles take aim at acne
MDedge Dermatology
The puzzling relationship between diet and acne
MDedge Dermatology
Triple-combination for severe acne avoids isotretinoin
MDedge Dermatology
A Dermatologist's Dilemma: Treatment Failure or Failure to Treat? [editorial]
MDedge Dermatology
Phototoxic and Photoallergic Potential of Tazarotene Foam 0.1% in 2 Phase 1 Patch Studies
MDedge Dermatology
New-Generation Radiofrequency Technology
MDedge Dermatology
Clindamycin Phosphate 1.2%&#8211;–Benzoyl Peroxide (5% or 2.5%) Plus Tazarotene Cream 0.1% for the Treatment of Acne
MDedge Dermatology